Everything below concerns Metabolite. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2026-01-22. Where a claim depends on a specific study, the study is described rather than over-claimed.
Preclinical research reported that GW501516 increased running endurance in mice and improved lipid profiles in some animal species. Early human trials explored effects on high-density lipoprotein cholesterol, triglycerides, and glucose handling, but the program was discontinued. Published human data are sparse and do not establish efficacy for any condition. Studies also examined PPAR delta in cancer biology, with conflicting findings across models. The relationship between receptor activation, tissue context, and disease risk remains an active area of investigation.
Anti-doping laboratories identify GW501516 and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is the usual matrix, and detection can occur after the parent compound has cleared from blood. The exact detection window depends on dose, formulation, individual metabolism, and assay sensitivity. Because the compound is prohibited at all times, athletes are subject to testing in and out of competition. Analytical methods continue to improve as new metabolites and designer analogs are characterized.
GW501516 acts as a ligand for PPAR delta, a nuclear receptor that regulates transcription of genes involved in fatty acid oxidation and energy use. Activation of this receptor in skeletal muscle shifts metabolism toward fat burning in animal models. The compound does not burn fat directly; it changes gene expression over hours to days. Researchers study it to understand metabolic flexibility and exercise adaptation. Effects observed in rodents are not automatically expected in humans.
Laboratory detection of GW501516 commonly uses liquid chromatography coupled with tandem mass spectrometry. The method can identify the parent compound or its metabolites in urine and blood after sample cleanup. Protein precipitation, solid-phase extraction, or enzymatic hydrolysis may precede analysis, depending on the matrix. Reference standards are required for accurate quantification and confirmation. Because the compound is not approved, testing often occurs in anti-doping, forensic, or research settings rather than routine clinical care. Results are reported with limits of detection and quantification.
Stability of GW501516 depends on form, temperature, light exposure, and moisture. Solid reference material is typically stored frozen or refrigerated in a desiccator and protected from light. Solutions in organic solvents such as dimethyl sulfoxide are often kept frozen in aliquots to reduce freeze-thaw cycling. Aqueous solubility is low, so aqueous stock solutions can be difficult to prepare without cosolvents. Degradation may appear as changes in chromatographic purity or mass spectral signal. Stability studies are needed to establish shelf life for any specific preparation.
| Property | Value | Notes |
|---|---|---|
| Molecular target | PPAR delta (NR1C2) | Ligand-activated nuclear receptor. |
| Primary tissues studied | Skeletal muscle, liver, adipose | Effects on fatty acid oxidation and energy use. |
| Typical detection matrix | Urine | Used in anti-doping analysis. |
| Common analytical method | LC-MS/MS | Detects parent compound and metabolites. |
| Sport regulatory class | Prohibited at all times | Listed as a metabolic modulator by WADA. |
Cardarine is prohibited in competitive sport under the World Anti-Doping Agency code, where it is classified as a metabolic modulator. It is not approved as a prescription medicine in the United States, European Union, or other major markets. Regulatory action has focused on its presence in sports and in products marketed as research chemicals. Because it has no accepted medical indication, supply is often unregulated. This status creates legal and safety uncertainties for anyone who encounters the substance.
Anti-doping laboratories detect GW501516 and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is the most common matrix, though blood and dried blood spots may also be used in some programs. Detection depends on factors such as dose, timing, metabolism, and the sensitivity of the assay. Published methods describe limits of detection in the low nanogram per milliliter range for related compounds. Exact detection windows are not fixed for all situations and remain an area of ongoing study.
Products sold as cardarine have been found to contain incorrect compounds, variable amounts, or no active ingredient at all. Independent testing is required to verify identity and purity. Common analytical approaches include high-performance liquid chromatography, mass spectrometry, and nuclear magnetic resonance for structural confirmation. These methods can distinguish GW501516 from related PPAR agonists and from unrelated steroids. For regulators and researchers, such verification is central to interpreting both biological results and adverse event reports.
GW501516 acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in transcription of genes related to lipid handling and energy use. Activation of PPARδ can shift skeletal muscle toward greater fatty acid oxidation in animal models, which is one reason it drew interest for metabolic disease and exercise research. The exact downstream effects depend on tissue, species, dose, and duration. Human data are sparse, so many proposed benefits remain hypotheses rather than established clinical outcomes.
Laboratory studies have examined GW501516 in cell cultures and rodents for conditions such as dyslipidemia, insulin resistance, and obesity. Some trials in humans were initiated, but development was discontinued after preclinical findings raised concerns about cancer in certain models. Those findings do not prove that the compound causes cancer in people, but they contributed to regulatory caution. Later reviews often describe the evidence as preliminary and insufficient for assessing long-term safety.
=== Additional references === Gerngross T, Slater S (February 2003). "Biopolymers and the environment". Science. 299 (5608): 822–5, author reply 822–5. doi:10.1126/science.299.5608.822. PMID 12574603. S2CID 41354773. Gerngross TU (June 1999). "Can biotechnology move us toward a sustainable society?". Nat. Biotechnol. 17 (6): 541–4. doi:10.1038/9843. PMID 10385316. S2CID 36258380.
Psilocybe baeocystis is a psilocybin mushroom of the family Hymenogastraceae. It contains the hallucinogenic compounds psilocybin, psilocin and baeocystin. The species is commonly known by various names such as bottle caps, knobby tops, blue bells, olive caps, blue Meanies.
=== 2003 === 15 March Space Shuttle: Human Time Bomb? about STS-107, which broke up on 1 February 2003; Bill Readdy of NASA; technology writer Dwayne A. Day; the shuttle engines burned 1.5 tonnes per second; physicist Ted Postol of MIT; Vladimir Titov and Gennady Strekalov deployed a launch escape system on Soyuz 7K-ST No.16L on 26 September 1983; the shuttle design was hampered by a need for a large-enough payload bay, to take 60-ft spy satellites for the USAF, and the shuttle's original companion launch vehicle (similar to the North American DC-3) was exchanged for a disposable fuel tank; in May 1995 for STS-70, woodpeckers destroyed a large part of the foam coating on the fuel tank next to Discovery on the launch pad - NASA bought six lifesize owls from a nearby supermarket to frighten the woodpeckers away; on 7 October 2002 on the launch of STS-112, foam broke away from the fuel tank, causing damage, which NASA ignored; Jeff Hoffmann; on 1 February 2003 at around 8am Nacogdoches, Texas was hit by debris. Narrated by Heather Couper, produced by Stuart Carter, directed by Alex Hearle, made by Pioneer Productions. Filmed, edited and broadcast only twenty three days after being commissioned Self-Experimenters, about self-experimentation in medicine; neuroscientist Simon Gandevia from the Prince of Wales Medical Research Institute (since 2010, Neuroscience Research Australia); Canadian thermophysiologist Gordon Giesbrecht at the University of Manitoba in Winnipeg; medicinal chemist and psychopharmacologist Sasha Shulgin; medicinal chemist David E.
Sources: en.wikipedia.org
=== Critical reception === In New Statesman, Fergal Kinney described Logan as "television's first truly irredeemable leading man," lauding him as a malevolent, ruthless figure rather than a sympathetic anti-hero. Kinney contrasted Logan's actions from Tony Soprano, Walter White, Don Draper, and Omar Little as fundamentally repulsive, receiving no redemption for his dark actions that lead to climate change, civilian death, and mass exploitation. Emily St. James of Vox noted that the monstrosity of Logan's character is critical to the formation of his children, emphasizing how "all they have known is damage." Cox's performances in multiple episodes were singled out as highlights. In an AV Club review of the episode "Which Side Are You On?", Cox's portrayal of Logan is described as "Trumpian" and "steals the scene." The humiliating game that Logan forces his family to play in "Hunting" has been described as "terrifying" and embelic of his character's cruelty. Cox's penultimate appearance in the series in "Rehearsal" was acclaimed by TVLine as both "summon[ing] a formidable energy" and "revealing just the slightest hint of vulnerability." Many critics drew comparisons between Logan and the Shakespearean character of King Lear. Obvious similarities between Logan and Lear include them both dividing their possessions to their three children, the siblings being forced to demonstrate their devotion to their father, and the mutual destruction that becomes of their entire family.
The oil is distilled from the wood of the entire tree including stump and roots. Australian sandalwood (S. spicatum) is unique in that the white sapwood does not require removal before distilling the oil, while Indian Sandalwood (S. album) does require removal of the sapwood prior to distillation.
=== Vascular protective effects === 1-MNA exerts beneficial effects on blood vessels through its action on the vascular endothelium. It improves the bioavailability of nitric oxide (NO), which is crucial for vasodilation, and regulates the activity of endothelial nitric oxide synthase (eNOS), the enzyme responsible for NO synthesis. These effects have been demonstrated in both in vivo and in vitro studies. Oral administration of 1-MNA has been shown to increase the diameter of the brachial artery (as measured by flow-mediated dilation, FMD) and stimulate NO release from human endothelial cells in both healthy individuals and those with hypercholesterolemia increased. Additionally, in cases of vascular dysfunction (e.g., hypertriglyceridemia or diabetes), 1-MNA restored normal NO-dependent vasodilation. By increasing NO bioavailability, 1-MNA may counteract endothelial dysfunction, support endothelial regeneration, and improve vascular function, particularly in the context of cardiovascular risk.
Sources: en.wikipedia.org
The mechanism of action of pantoprazole is to inhibit the final step in gastric acid production. In the gastric parietal cell of the stomach, pantoprazole covalently binds to the H+/K+ ATP pump to inhibit gastric acid and basal acid secretion. The covalent binding prevents acid secretion for up to 24 hours and longer. Pantoprazole is metabolized in the liver by the cytochrome P450 system. Metabolism mainly consists of demethylation by CYP2C19 followed by sulfation. Another metabolic pathway is oxidation by CYP3A4. Pantoprazole metabolites are not thought to have any pharmacological significance. It is usually given with a prokinetic drug because of inactivity in the acidic environment of the stomach. Pantoprazole binds irreversibly to H+K+ATPase (proton pumps) to suppress the secretion of acid. Due to irreversible binding of the pumps, new pumps have to be made before acid production can be resumed. The drug's plasma half-life is about two hours. After administration, the time for the drug to reach peak plasma concentrations is 2 to 3 hours. The percentage of the drug that is protein bound is 98%.
As per the Taliban officials, 55 Pakistani soldiers were killed, and several others were captured. Taliban-led Afghanistan's officials further added that one military headquarters and 19 border outposts had been captured, while 4 border outposts were destroyed during the operation. Zabihullah Mujahid named seven of the border outposts that Taliban officials claimed to have captured. According to reports, the outposts were located inside Afghanistan, and it remained unclear how border outposts belonging to Pakistani forces were located on Afghan soil. At midnight local time (19:30 GMT), the Taliban-led Afghan Ministry of Defense announced the end of its four-hour operation. Pakistani officials rejected Taliban claims and stated that military action against Taliban forces was continuing. They further added that the attack had been repulsed, that the Taliban had suffered heavy losses, and that two Pakistani soldiers had been killed and three others were injured during the four-hour engagement. In response to the Taliban's operation, Pakistan carried out air and ground strikes against Afghan Taliban positions in Kabul, Kandahar, Paktia, and Nangarhar. Faisal Karim Kundi, governor of Khyber Pakhtunkhwa, stated that the Afghan Taliban started the war and Pakistan will be the one to end it, while Khawaja Asif, Pakistan's defence minister, announced the start of an "open war" between the two countries. Pakistani officials stated that around 133 Taliban fighters were killed and more than 200 were injured during the clashes and subsequent operation.
=== Sexual stimulation and arousal === The clitoris has an abundance of nerve endings, and is the human female's most erogenous part of the body. When sexually stimulated, it may incite sexual arousal, which may result from mental stimulation (sexual fantasy), activity with a sexual partner, or masturbation, and can lead to orgasm. The most effective sexual stimulation of this organ is usually manually or orally, which is often referred to as direct clitoral stimulation; in cases involving sexual penetration, these activities may also be referred to as additional or assisted clitoral stimulation. Direct stimulation involves physical stimulation to the external anatomy of the clitoris – glans, hood, and shaft. Stimulation of the labia minora, due to it being connected with the glans and hood, may have the same effect as direct clitoral stimulation. Though these areas may also receive indirect physical stimulation during sexual activity, such as when in friction with the labia majora, indirect clitoral stimulation is more commonly attributed to penile-vaginal penetration. Penile-anal penetration may also indirectly stimulate the clitoris by the shared sensory nerves (especially the pudendal nerve, which gives off the inferior anal nerves and divides into two terminal branches: the perineal nerve and the dorsal nerve of the clitoris).
Sources: en.wikipedia.org
It binds to and activates PPAR delta, a nuclear receptor that controls expression of genes related to fatty acid oxidation. This mechanism can alter energy metabolism in animal models. It is not a direct stimulant or fat-burning enzyme.
Early-stage trials examined lipid and glucose markers, but the development program was discontinued. Published human results are limited and do not support approved use for any indication. Claims of performance or health benefits remain unproven.
Yes. Laboratories use LC-MS/MS to detect GW501516 and its metabolites in urine. Detection depends on timing and sensitivity, but the substance is banned at all times.
LC-MS/MS is common, often after sample cleanup. The assay targets GW501516 or its metabolites.